249 related articles for article (PubMed ID: 25398991)
1. The cytoplasmic peptide:N-glycanase (Ngly1)-basic science encounters a human genetic disorder.
Suzuki T
J Biochem; 2015 Jan; 157(1):23-34. PubMed ID: 25398991
[TBL] [Abstract][Full Text] [Related]
2. The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.
Suzuki T; Huang C; Fujihira H
Gene; 2016 Feb; 577(1):1-7. PubMed ID: 26611529
[TBL] [Abstract][Full Text] [Related]
3. Ever-expanding NGLY1 biology.
Suzuki T; Yoshida Y
J Biochem; 2022 Feb; 171(2):141-143. PubMed ID: 34969094
[TBL] [Abstract][Full Text] [Related]
4. Endo-β-N-acetylglucosaminidase forms N-GlcNAc protein aggregates during ER-associated degradation in Ngly1-defective cells.
Huang C; Harada Y; Hosomi A; Masahara-Negishi Y; Seino J; Fujihira H; Funakoshi Y; Suzuki T; Dohmae N; Suzuki T
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1398-403. PubMed ID: 25605922
[TBL] [Abstract][Full Text] [Related]
5. Lethality of mice bearing a knockout of the Ngly1-gene is partially rescued by the additional deletion of the Engase gene.
Fujihira H; Masahara-Negishi Y; Tamura M; Huang C; Harada Y; Wakana S; Takakura D; Kawasaki N; Taniguchi N; Kondoh G; Yamashita T; Funakoshi Y; Suzuki T
PLoS Genet; 2017 Apr; 13(4):e1006696. PubMed ID: 28426790
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic peptide:N-glycanase cleaves N-glycans on a carboxypeptidase Y mutant during ERAD in Saccharomyces cerevisiae.
Hosomi A; Suzuki T
Biochim Biophys Acta; 2015 Apr; 1850(4):612-9. PubMed ID: 25497214
[TBL] [Abstract][Full Text] [Related]
7. A plant peptide: N-glycanase orthologue facilitates glycoprotein ER-associated degradation in yeast.
Masahara-Negishi Y; Hosomi A; Della Mea M; Serafini-Fracassini D; Suzuki T
Biochim Biophys Acta; 2012 Oct; 1820(10):1457-62. PubMed ID: 22659524
[TBL] [Abstract][Full Text] [Related]
8. Fluorescently labeled inhibitor for profiling cytoplasmic peptide:N-glycanase.
Hagihara S; Miyazaki A; Matsuo I; Tatami A; Suzuki T; Ito Y
Glycobiology; 2007 Oct; 17(10):1070-6. PubMed ID: 17640972
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
Miao X; Wu J; Chen H; Lu G
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
[TBL] [Abstract][Full Text] [Related]
10. Physiological importance of NGLY1, as revealed by rodent model analyses.
Fujihira H; Asahina M; Suzuki T
J Biochem; 2022 Feb; 171(2):161-167. PubMed ID: 34580715
[TBL] [Abstract][Full Text] [Related]
11. A commentary on 'Patient-derived gene and protein expression signatures of NGLY1 deficiency'.
Suzuki T
J Biochem; 2024 Mar; 175(3):221-223. PubMed ID: 38156787
[TBL] [Abstract][Full Text] [Related]
12. Dual enzymatic properties of the cytoplasmic peptide: N-glycanase in C. elegans.
Suzuki T; Tanabe K; Hara I; Taniguchi N; Colavita A
Biochem Biophys Res Commun; 2007 Jul; 358(3):837-41. PubMed ID: 17509531
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic peptide:N-glycanase and catabolic pathway for free N-glycans in the cytosol.
Suzuki T
Semin Cell Dev Biol; 2007 Dec; 18(6):762-9. PubMed ID: 17950635
[TBL] [Abstract][Full Text] [Related]
14. New perspectives on the mutated NGLY1 enigma.
Tickotsky-Moskovitz N
Med Hypotheses; 2015 Nov; 85(5):584-5. PubMed ID: 26228302
[TBL] [Abstract][Full Text] [Related]
15. Identification of PNGase-dependent ERAD substrates in Saccharomyces cerevisiae.
Hosomi A; Fujita M; Tomioka A; Kaji H; Suzuki T
Biochem J; 2016 Oct; 473(19):3001-12. PubMed ID: 27433019
[TBL] [Abstract][Full Text] [Related]
16. Physiological and molecular functions of the cytosolic peptide:N-glycanase.
Hirayama H; Hosomi A; Suzuki T
Semin Cell Dev Biol; 2015 May; 41():110-20. PubMed ID: 25475175
[TBL] [Abstract][Full Text] [Related]
17. A role for N-glycanase in the cytosolic turnover of glycoproteins.
Hirsch C; Blom D; Ploegh HL
EMBO J; 2003 Mar; 22(5):1036-46. PubMed ID: 12606569
[TBL] [Abstract][Full Text] [Related]
18. Ngly1 -/- rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems.
Asahina M; Fujinawa R; Nakamura S; Yokoyama K; Tozawa R; Suzuki T
Hum Mol Genet; 2020 Jun; 29(10):1635-1647. PubMed ID: 32259258
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
Owings KG; Lowry JB; Bi Y; Might M; Chow CY
Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]